MedTrace Logo

Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Mental Illness

NCT04598425 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-09-30

No results posted yet for this study

Summary

Insomnia is common in patients with co-morbid mental illness and sleeping difficulties is a frequent complaint in most psychological disorders. Mental illness may cause sleep problems, however, sleep problems like insomnia, may also cause or exacerbate mental illness. Insomnia may aggravate symptoms of depression, anxiety and fatigue, and reduce daily functioning in patients with co-morbid insomnia and mental illness. This project aims to evaluate a course offered to patients with insomnia and mental illness at Diakonhjemmet Hospital. The course is based on cognitive behavioral therapy, a documented treatment for insomnia.

Conditions

  • Insomnia
  • Insomnia Chronic
  • Insomnia Due to Mental Disorder
  • Insomnia, Psychophysiological
  • Sleep Disorder
  • Sleep Initiation and Maintenance Disorders
  • Sleep Disturbance
  • Mental Illness
  • Psychological Disorder
  • Depression, Anxiety

Interventions

BEHAVIORAL

Cognitive behavioral therapy for insomnia (CBTi)

Patients will undergo a 7 sessions course in cognitive behavioral therapy for insomnia.

Sponsors & Collaborators

  • Diakonhjemmet Hospital

    lead OTHER

Principal Investigators

  • Kåre Osnes, M.D., Ph.D. · Department of Psychiatry, Diakonhjemmet Hospital, Oslo, Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598425 on ClinicalTrials.gov